NOVARTIS AG
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$160.79
-0.19%
Alpha Vantage · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
+14.0%
3 months
+4.6%
6 months
+9.7%
1 year
+33.8%
Year to date
+18.9%
52-week range
$120.22 – $165.33
Fundamental snapshot
Latest reported period: Sep 30, 2026
Market cap
$304.86B
P/E
30.4
P/B
8.2
P/S
5.3
Revenue
$57.36B
Net income
$10.03B
Diluted EPS
5.24
Gross margin
74.90%
Net margin
17.50%
Return on equity
24.60%
Total debt
$48.31B
Cash
$8.87B
Free cash flow
$15.69B
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Sep 30, 2026 | $15.03B | $1.2B | 76.00% | 8.00% | $5.11B |
| Jun 30, 2026 | $14.95B | $3.26B | 75.20% | 21.80% | $5.59B |
| Mar 31, 2026 | $13.52B | $3.16B | 74.40% | 23.30% | $3.34B |
| Dec 31, 2025 | $13.86B | $2.41B | 73.90% | 17.40% | $1.66B |
| Sep 30, 2025 | $14.36B | $3.93B | 75.40% | 27.40% | $6.22B |
| Jun 30, 2025 | $14.84B | $4.04B | 77.60% | 27.20% | $6.33B |
| Mar 31, 2025 | $13.62B | $3.61B | 76.30% | 26.50% | $3.4B |
| Dec 31, 2024 | $13.56B | $2.82B | 75.50% | 20.80% | $3.68B |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent NVS news
All market newsNo ticker-linked stories are in the current archive.